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ABSTRACT 
The conclusions of the European Food Safety Authority (EFSA) following the peer review of the initial risk 
assessments carried out by the competent authority of the rapporteur Member State, Hungary, for the pesticide 
active substance valifenalate are reported.  The context of the peer review was that required by Commission 
Regulation (EU) No 188/2011.  The conclusions were reached on the basis of the evaluation of the representative 
use of valifenalate as a fungicide on grapes. The reliable endpoints concluded as being appropriate for use in 
regulatory risk assessment, derived from the available studies and literature in the dossier peer reviewed, are 
presented.  Missing information identified as being required by the regulatory framework is listed.  Concerns are 
identified. 
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SUMMARY 
Valifenalate is a new active substance for which in accordance with Article 6(2) of Council Directive 
91/414/EEC Hungary (hereinafter referred to as the ‘RMS’) received an application from Isagro S.p.A. 
for approval.  Complying with Article 6(3) of Directive 91/414/EEC, the completeness of the dossier 
was checked by the RMS.  The European Commission recognised in principle the completeness of the 
dossier by Commission Decision 2006/586/EC. 
The RMS provided its initial evaluation of the dossier on valifenalate in the Draft Assessment Report 
(DAR), which was received by the EFSA on 19 February 2008.  In accordance with Article 11(6) of 
Commission Regulation (EU) No 188/2011 additional information was requested from the applicant.  
The RMS’s evaluation of the additional information was provided in the format of an updated DAR.  
The peer review was initiated on 4 May 2012 by dispatching the DAR for consultation of the Member 
States and the applicant Isagro S.p.A. 
Following consideration of the comments received on the DAR, it was concluded that EFSA should 
conduct an expert consultation in the areas of mammalian toxicology and environmental fate and 
behaviour and should adopt a conclusion on whether valifenalate can be expected to meet the 
conditions provided for in Article 5 of Directive 91/414/EEC, in accordance with Article 8 of 
Commission Regulation (EU) No 188/2011. 
The conclusions laid down in this report were reached on the basis of the evaluation of the 
representative uses of valifenalate as a fungicide on grapes, as proposed by the applicant. Full details 
of the representative uses can be found in Appendix A to this report. 
No data gaps or areas of concern were identified for the section on identity, physical and chemical 
properties and analytical methods. 
In the area of mammalian toxicology no data gaps were identified.  A critical area of concern is related 
to the compliance of the batches tested with the proposed technical specification. 
No data gaps or areas of concern were identified in the residues area. The consumer risk assessment 
can be finalised. 
A data gap for the groundwater assessment of the aged column leachate metabolite S5 was identified 
in the fate and behaviour section. No critical areas of concern have been identified at this stage.  
No data gaps were identified for the section on ecotoxicology, however, a critical area of concern is 
related to the compliance of the batches tested with the proposed technical specification.   
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BACKGROUND 
In accordance with Article 80(1)(a) of Regulation (EC) No 1107/2009,
3 Council Directive 
91/414/EEC
4 continues to apply with respect to the procedure and conditions for approval for active 
substances for which a decision recognising in principle the completeness of the dossier was adopted 
in accordance with Article 6(3) of that Directive before 14 June 2011. 
Commission Regulation (EU) No 188/2011
5 (hereinafter referred to as ‘the Regulation’) lays down the 
detailed rules for the implementation of Council Directive 91/414/EEC as regards the procedure for 
the assessment of active substances which were not on the market on 26 July 1993.  This regulates for 
the European Food Safety Authority (EFSA) the procedure for organising the consultation of Member 
States and the applicant(s) for comments on the initial evaluation in the Draft Assessment Report 
(DAR) provided by the rapporteur Member State (RMS), and the organisation of an expert 
consultation, where appropriate.   
In accordance with Article 8 of the Regulation, EFSA is required to adopt a conclusion on whether the 
active substance is expected to meet the conditions provided for in Article 5 of Directive 91/414/EEC 
within 4 months from the end of the period provided for the submission of written comments, subject 
to an extension of 2 months where an expert consultation is necessary, and a further extension of upto 
8 months where additional information is required to be submitted by the applicant(s) in accordance 
with Article 8(3).  
In accordance with Article 6(2) of Council Directive 91/414/EEC, Hungary (hereinafter referred to as 
the ‘RMS’), received an application from Isagro S.p.A. for approval of the active substance 
valifenalate (formerly referred to as valiphenal). Complying with Article 6(3) of Directive 
91/414/EEC, the completeness of the dossier was checked by the RMS.  The European Commission 
recognised in principle the completeness of the dossier by Commission Decision 2006/586/EC.
6 
The RMS provided its initial evaluation of the dossier on valifenalate in the DAR, which was received 
by the EFSA on 19 February 2008.  In accordance with Article 11(6) of Commission Regulation (EU) 
No 188/2011 additional information was requested from the applicant.  The RMS’s evaluation of the 
additional information was provided in the format of an updated DAR (Hungary, 2012).  The peer 
review was initiated on 4 May 2012 by dispatching the DAR to Member States and the applicant 
Isagro S.p.A. for consultation and comments.  In addition, the EFSA conducted a public consultation 
on the DAR.  The comments received were collated by the EFSA and forwarded to the RMS for 
compilation and evaluation in the format of a Reporting Table.  The applicant was invited to respond 
to the comments in column 3 of the Reporting Table. The comments and the applicant’s response were 
evaluated by the RMS in column 3. 
The need for expert consultation and the necessity for additional information to be submitted by the 
applicant in accordance with Article 8(3) of the Regulation were considered in a telephone conference 
between the EFSA, the RMS, and the European Commission on 30 August 2012. On the basis of the 
comments received, the applicant’s response to the comments and the RMS’s evaluation thereof it was 
concluded that additional information should be requested from applicant, and the EFSA should 
                                                      
3 Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing 
of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC. OJ No L 309, 
24.11.2009, p. 1-50. 
4 Council Directive 91/414/EEC of 15 July 1991 concerning the placing of plant protection products on the market. OJ L 230, 
19.8.1991, p. 1-32, as last amended.  
5 Commission Regulation (EU) No 188/2011 of 25 February 2011 laying down detailed rules for the implementation of 
Council Directive 91/414/EEC as regards the procedure for the assessment of active substances which were not on the market 
2 years after the date of notification of that Directive. OJ No L 53, 26.2.2011, p. 51-55. 
6 Commission Decision 2006/586/EC of 25 August 2006 recognising in principle the completeness of the dossiers submitted 
for detailed examination in view of the possible inclusion of chromafenozide, halosulfuron, tembotrione, valiphenal and 
Zucchini yellow mosaic virus – weak strain in Annex I to Council Directive 91/414/EEC. OJ No L 236, 31.8.2006, p. 31-33. Peer review of the pesticide risk assessment of the active substance valifenalate
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organise an expert consultation in the areas of mammalian toxicology and environmental fate and 
behaviour. 
The outcome of the telephone conference, together with EFSA’s further consideration of the 
comments is reflected in the conclusions set out in column 4 of the Reporting Table. All points that 
were identified as unresolved at the end of the comment evaluation phase and which required further 
consideration, including those issues to be considered in an expert consultation, and the additional 
information to be submitted by the applicant were compiled by the EFSA in the format of an 
Evaluation Table. 
The conclusions arising from the consideration by the EFSA, and as appropriate by the RMS, of the 
points identified in the Evaluation Table, together with the outcome of the expert consultation where 
this took place, were reported in the final column of the Evaluation Table. 
A final consultation on the conclusions arising from the peer review of the risk assessment took place 
with Member States via a written procedure in May 2013.   
This conclusion report summarises the outcome of the peer review of the risk assessment on the active 
substance and the representative formulation evaluated on the basis of the representative use as a 
fungicide on grapes, as proposed by the applicant. A list of the relevant end points for the active 
substance as well as the formulation is provided in Appendix A. In addition, a key supporting 
document to this conclusion is the Peer Review Report, which is a compilation of the documentation 
developed to evaluate and address all issues raised in the peer review, from the initial commenting 
phase to the conclusion. The Peer Review Report (EFSA, 2013) comprises the following documents, 
in which all views expressed during the course of the peer review, including minority views, can be 
found: 
•  the comments received on the DAR, 
•  the Reporting Table (30 August 2012),  
•  the Evaluation Table (24 May 2013), 
•  the reports of the scientific consultation with Member State experts (where relevant), 
•  the comments received on the assessment of the additional information (where relevant), 
•  the comments received on the draft EFSA conclusion. 
Given the importance of the DAR including its addendum (compiled version of April 2013 containing 
all individually submitted addenda (Hungary, 2013)) and the Peer Review Report, both documents are 
considered respectively as background documents A and B to this conclusion.  
It is recommended that this conclusion report and its background documents would not be accepted to 
support any registration outside the EU for which the applicant has not demonstrated to have 
regulatory access to the information on which this conclusion report is based. Peer review of the pesticide risk assessment of the active substance valifenalate
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THE ACTIVE SUBSTANCE AND THE FORMULATED PRODUCT 
Valifenalate is the ISO common name for methyl N-(isopropoxycarbonyl)-L-valyl-(3RS)-3-(4-
chlorophenyl)-β-alaninate (IUPAC). 
The representative formulated product for the evaluation was ‘JAVA F (IR5885 F)’, a water 
dispersible granule (WG) containing 60 g/kg valifenalate and 480 g/kg folpet.  
The representative uses evaluated comprise applications by spraying against downy mildew on grapes. 
Full details of the GAP can be found in the list of end points in Appendix A. 
CONCLUSIONS OF THE EVALUATION 
1.  Identity, physical/chemical/technical properties and methods of analysis 
The following guidance documents were followed in the production of this conclusion: 
SANCO/3030/99 rev.4 (European Commission, 2000) and SANCO/825/00 rev. 8.1 (European 
Commission, 2010). 
The minimum purity of the active substance is 980 g/kg. No FAO specification exists. Technical 
valifenalate is an equimolar mixture of the diastereomers (S,R) and (S,S). 
The assessment of the data package revealed no issues that need to be included as critical areas of 
concern with respect to the identity, physical, chemical and technical properties of valifenalate or the 
representative formulation. The main data regarding the identity of valifenalate and its physical and 
chemical properties are given in Appendix A. 
Adequate analytical methods are available for the determination of valifenalate in technical material 
and in the representative formulation as well as for the determination of the respective impurities in 
the technical material.  
Residues of valifenalate in food and feed of plant origin can be monitored by HPLC-MS/MS with 
LOQs of 0.01 mg/kg. A method to monitor residues in food of animal origin is not required as no 
MRL was proposed.  
Appropriate HPLC-MS/MS methods exist for monitoring valifenalate and the metabolite IR-5839 in 
soil with LOQs of 0.05 mg/kg for each compound. The soil metabolite PCBA can be monitored by 
HRGC/ECD with a LOQ of 0.05 mg/kg. Valifenalate and the metabolite IR-5839 can be monitored in 
groundwater and drinking water by HPLC-MS/MS with a LOQ of 0.1 µg/L for each compound.  The 
metabolite PCBA can be determined in groundwater and drinking water by HRGC/ECD with a LOQ 
of 0.1 µg/L.  The LOQ for monitoring valifenalate and the respective two metabolites in surface water 
is 10 µg/L for each compound. An appropriate HPLC-MS/MS method exists for monitoring 
valifenalate in air with a LOQ of 0.1 µg/m
3. 
A method for residues in body fluids and tissues is not required as the active substance is not classified 
as toxic or very toxic, however an HPLC-MS/MS method exists for monitoring valifenalate in milk 
and biological tissues with a LOQ of 0.02 mg/kg. 
2.  Mammalian toxicity 
The following guidance documents were followed in the production of this conclusion: 
SANCO/221/2000 rev. 10 - final (European Commission, 2003), SANCO/222/2000 rev. 7 (European 
Commission, 2004). 
One impurity was tested up to 0.92 g/kg in the mammalian toxicological tests, however it is proposed 
to be specified at 12 g/kg. The impurity is of no concern up to the level tested in the toxicological 
batches, however the toxicological compliance with the specification cannot be proven. The Peer review of the pesticide risk assessment of the active substance valifenalate
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mentioned DEREK alerts, not reported in detail in the DAR, cannot be addressed with the assessment 
of the toxicological properties of valifenalate, due to the different amounts. 
Valifenalate was discussed in the Pesticides Peer Review Meeting 98 held in November 2012. 
Valifenalate is not acutely toxic via oral, dermal and inhalation routes; it is not a skin or eye irritant, or 
a skin sensitiser. The target organ after repeated administration in mouse (most sensitive species) is 
liver, which showed increased weight, hepatocyte vacuolation and increased incidence of 
hepatocellular tumours in a long-term study in both sexes: in the absence of a mechanistic study, this 
was considered to trigger a proposal of classification with R40
7 (“Limited evidence of a carcinogenic 
effect“). The relevant short-term No Accepted Observed Adverse Effect Levels (NOAEL) are 15 
mg/kg bw per day, 150 mg/kg bw per day and 7 mg/kg bw per day in mouse, rat and dog, respectively. 
Valifenalate is not mutagenic, and is neither a reproductive (relevant parental, reproductive and 
offspring NOAELs 80 mg/kg bw per day) nor a developmental toxicant (relevant maternal and 
developmental NOAELs 1000 mg/kg bw per day in both rats and rabbits). The relevant long-term 
toxicity NOAELs in mouse and rat are 16.8 mg/kg bw per day and 150 mg/kg bw per day, 
respectively. The Acceptable Daily Intake (ADI) and the Acceptable Operator Exposure Level 
(AOEL) are 0.07 mg/kg bw per day based on the 1-year dog study, applying an uncertainty factor of 
100. Based on the toxicological profile of valifenalate the setting of an Acute Reference Dose (ARfD) 
is not necessary. The operator, worker and bystander estimated exposures to valifenalate are below the 
AOEL. 
3.  Residues 
The assessment in the residue section below is based on the guidance documents listed in the 
document 1607/VI/97 rev.2 (European Commission, 1999), and the JMPR recommendations on 
livestock burden calculations stated in the 2004 and 2007 JMPR reports. 
The metabolism of valifenalate was investigated in grapes, tomato (leaves), potato and lettuce, which 
cover three metabolism groups. In the matrices tested (grapes, tomato, potato and lettuce), valifenalate 
was not extensively metabolised. The majority of the parent compound remained unchanged. Only 
minor non-significant metabolites were formed. As the major component of the residue remains as 
valifenalate the residue definition for plants for risk assessment and monitoring is valifenalate. The 
ratio of the isomers was shown to be unchanged. 
As grapes are not in a rotation, a study on residues in succeeding crops is not required. 
Although not required for the representative use on grapes a goat metabolism study was available. The 
concentration of radioactivity found in milk and muscle was negligible (0.003 mg/kg), and was very 
low in fat (0.011 mg/kg), kidneys (0.045 mg/kg) and liver (0.109 mg/kg). 
The compounds found in tissues and milk, always at very low concentrations, were valifenalate (max. 
0.007 mg/kg in fat), IR-5839 (max. 0.066 mg/kg in liver) and ß-pCl-phenylalanine (max. 0.004 mg/kg 
in kidneys). From this study a residue definition for risk assessment and monitoring is valifenalate and 
IR-5839. 
A full set of residue trials was available for the North and South of Europe resulting in a HR of 0.084 
mg/kg and a STMR of 0.059 mg/kg. Storage stability data were available to support the storage of the 
samples from the trials. A hydrolysis processing study was not available however, it is not required as 
the percentage of the ADI used is low.  Processing studies were available for grapes. 
                                                      
7 It should be noted that classification is formally proposed and decided in accordance with Regulation (EC) No 1272/2008.  
Proposals for classification made in the context of the evaluation procedure under Regulation (EC) No 1107/2009 are not 
formal proposals.  Peer review of the pesticide risk assessment of the active substance valifenalate
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The risk assessment for consumers resulted in intakes amounting to only 1.7 % of the ADI. An ARfD 
has not been set. The proposed EU MRL for grapes is 0.2 mg/kg.  
4.  Environmental fate and behaviour 
The fate and behaviour section of the updated DAR of valifenalate was discussed in the Pesticides 
Peer Review Meeting 101 (March 2013). 
The route of degradation of valifenalate (
14C labelled at the Cl-phenyl ring; 54 % SS, 46 % SR) in soil 
under dark aerobic conditions at 20 ºC was investigated in a sandy loam (USDA) soil.  The rate of 
degradation of valifenalate under dark aerobic conditions at 20 ºC was investigated in three soils in 
addition to that investigated in the route study. Valifenalate is very low persistent in soil and rapidly 
forms the major metabolite IR-5839 max 46.45 – 75.34 % AR that also exhibits very low persistence 
and is rapidly degraded to PCBA (4-chlorobenzoic acid) max. 36.04 – 50.21 % AR. The rate of 
degradation of metabolite PCBA under dark aerobic conditions at 20 ºC was investigated in a separate 
study with the same three soils. According to the results of this study, metabolite PCBA may be 
considered low persistent in soil. Degradation of the diastereomer SR was faster than degradation of 
diastereomer SS. In the updated dossier an additional study is available that confirms the selective 
diastereomeric degradation in soil and that no racemisation of any of the asymmetric centres in the 
molecule occur in soil or water. Unextractable radioactivity increased up to 23.98 – 27.68 % AR and 
volatiles trapped in the alkaline trap (assumed to be CO2 on the basis of evidence provided by a new 
study presented in the updated dossier) increased up to 17.55 - 26.96 % AR. No data on degradation in 
soil under anaerobic conditions were provided and no study has been required taking into account the 
representative uses proposed. Photolysis of valifenalate in soil was investigated in a microbially active 
soil under moist and dry conditions at 20 ºC. Photolysis is not expected to contribute to the dissipation 
of valifenalate in soil under normal environmental conditions. PECs in soil were calculated for parent 
valifenalate and the metabolites IR-5839 and PCBA for the representative use in grapes based on 
standard calculation and worst case assumptions.  
Batch soil adsorption / desorption studies were performed with valifenalate in five soils and with 
metabolites IR-5839 and PCBA in three soils. According to these studies valifenalate may be 
considered to exhibit low to medium mobility in soil, metabolite IR-5839 very high to high mobility 
and metabolite PCBA very high to medium mobility. An aged column leaching study in two soils was 
submitted in the original dossier. In these experiments in addition to soil metabolites IR-5839 and 
PCBA a new metabolite named S5 was observed to reach levels up to 5 % AR and up to 1.5 g / L in 
the leachate. The need to identify and assess this metabolite was identified during the peer review of 
the original dossier. In the updated dossier an additional soil incubation study was provided by the 
applicant, who claimed that the leachate metabolite S5 could be identified there. However, Member 
State experts agreed that the evidence that the aged column leachate metabolite S5 had actually been 
identified and properly addressed was very weak. Therefore, the experts identified a data gap for the 
finalisation of the groundwater assessment of the aged column leachate metabolite S5. 
Hydrolysis of valifenalate in water was investigated at pH 4, 7 and 9.  Valifenalate is stable at pH 4, 
hydrolyses slowly at pH 7 and is rapidly hydrolysed at pH 9. The main hydrolysis product at pH 9 was 
IR-5839. The hydrolysis of metabolites IR-5839 and PCBA was investigated in a separate study. Both 
metabolites were shown to be stable to hydrolysis under normal environmental conditions. Aqueous 
photolysis of valifenalate was not investigated because neither the parent nor the metabolites present 
significant absorbance at   290 nm ( < 10). Valifenalate is not readily biodegradable according to 
the available study.  
The fate and behaviour of valifenalate in dark aerobic water / sediment systems was investigated in a 
study with two systems. Valifenalate partitioned to the sediment to a very minor extent (max 1.79 % 
AR after 1 d) and most of the product remained in the water phase. Degradation was relatively fast in 
both systems (DT50 whole system = 4.5 – 4.71 d). Two major metabolites were found in the system: IR-
5839 (max. 52.8 – 56.34 % AR) and PCBA (max. 8.16 – 13.77 % AR). Only metabolite IR-5839 Peer review of the pesticide risk assessment of the active substance valifenalate
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exceeded 10 % in the sediment (max. 12.7 – 16.2 %). Mineralization was practically negligible and the 
non-extractable residue in the sediment grew up to 9 – 16.24 % AR after 22 d (end of the study). 
PECSW were calculated for parent and the major metabolites IR-5839 and PCBA with FOCUS SW 
tools up to step 2. Additionally, FOCUS SW step 3 PECSW/sed were calculated for the parent to confirm 
that the step 2 values used for the ecotoxicological risk assessment were not exceeded by the step 3 
results (FOCUS, 2001).  
The potential for groundwater contamination was assessed by calculation of the 80th percentile 20 
years annual average leachate concentrations of valifenalate, IR-5839 and PCBA at 1m depth with 
FOCUS GW PELMO 4.4.3 and PEARL 4.4.4 model (FOCUS, 2009). The limit of 0.1 g / L was not 
exceeded by any of these components in the seven relevant scenarios. However, there is an 
outstanding data gap for the finalisation of the groundwater assessment of the aged column leachate 
metabolite S5. 
5.  Ecotoxicology 
The risk assessment was based on the following documents: European Commission (2002a, 2002b, 
2002c), SETAC (2001). 
The compliance of the batches tested in the ecotoxicology data package with the proposed 
specification could not be demonstrated. 
It should be noted that the representative formulation (‘JAVA IR5885 F’) contains an additional active 
substance (folpet) and the ecotoxicological risk assessment for the formulated product was not 
completed. 
The risk via dietary exposure of valifenalate to birds (acute, short-term and long-term) and to 
mammals (acute and long-term) was assessed as low at the first tier level for the representative use. A 
risk assessment for secondary poisoning and consumption of contaminated water was not triggered.  
Toxicity studies were available on fish, aquatic invertebrates, sediment-dwelling organisms and algae 
with valifenalate, and (except for sediment-dwelling organisms), with the formulated product ‘JAVA 
IR5885 F’ and the metabolites IR-5839 and PCBA. Tests with the formulation containing a second 
active substance (folpet) suggest much higher toxicity to all aquatic organisms compared to technical 
valifenalate. The risk was assessed as low for the active substance and the metabolites at FOCUS step 
2.  Since the toxicity expressed in terms of valifenalate of the formulated product ‘JAVA IR5885 F’ 
was higher than the technical, a risk assessment was carried out by taking into account the initial 
maximum PECsw and the drift as the main route of exposure. The risk was assessed as low with the 
application of mitigation measures comparable to no-spray buffer zones up to 20 m. However, it 
should be noted that entry routes other than drift for the second active substance were not taken into 
account in the risk assessment, therefore the risk assessment for the formulated product cannot be 
considered completed. 
The risk from valifenalate was assessed as low for bees, non-target arthropods, earthworms, soil 
microorganisms, terrestrial non-target plants and biological methods for sewage treatment plants.  
 Peer review of the pesticide risk assessment of the active substance valifenalate
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6.  Overview of the risk assessment of compounds listed in residue definitions triggering assessment of effects data for the environmental 
compartments 
6.1.  Soil 
Compound 
(name and/or code)  Persistence Ecotoxicology 
valifenalate  Very low (DT50 = 0.14 – 0.37 d)  Low risk 
IR-5839  Very low (DT50 = 0.3 – 0.63 d)  Low risk 
PCBA Low  (DT50 = 2.00 – 9.52 d)  Low risk 
6.2.  Ground water 
Compound 
(name and/or code)  Mobility in soil 
>0.1  μg/L 1m depth for 
the representative uses
(at least one FOCUS 
scenario or relevant 
lysimeter) 
Pesticidal activity  Toxicological relevance  Ecotoxicological activity 
valifenalate  low to medium (KFoc = 
375 – 2134 mL / g)  FOCUS GW: no  Yes   Yes  Low risk 
IR-5839  very high to high (KFoc = 
34.32 – 95.28 mL / g)  FOCUS GW: no  Yes  
Rat oral LD50 > 2000 
mg/kg bw 
No genotoxic potential 
No further data available, 
not needed 
Low risk Peer review of the pesticide risk assessment of the active substance valifenalate
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PCBA  very high to medium (KFoc 
= 26.97 – 265.33 mL / g)  FOCUS GW: no  No data, not needed 
Rat oral LD50 1170 
mg/kg bw 
No genotoxic potential 
No further data available, 
not needed 
Low risk 
S5 (aged column leaching 
leachate metabolite) 
No data (metabolite not 
properly identified)  Data gap  No data, not needed  No data available  Pending on the data gap 
identified in section 4. 
6.3.  Surface water and sediment 
Compound 
(name and/or code)  Ecotoxicology 
valifenalate Low  risk 
IR-5839 Low  risk 
PCBA Low  risk 
6.4.  Air 
Compound 
(name and/or code)  Toxicology 
valifenalate  Not acutely toxic via inhalation 
 Peer review of the pesticide risk assessment of the active substance valifenalate
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7.  List of studies to be generated, still ongoing or available but not peer reviewed 
This is a complete list of the data gaps identified during the peer review process, including those areas 
where a study may have been made available during the peer review process but not considered for 
procedural reasons (without prejudice to the provisions of Article 7 of Directive 91/414/EEC 
concerning information on potentially harmful effects). 
  Groundwater assessment of the aged column leachate metabolite S5. In case, as a result of new 
data, 0.1 µg/L was expected to be exceeded by S5, the relevance of this metabolite would need to 
be addressed (relevant for all representative uses evaluated; submission date proposed by the 
applicant: no date proposed; see section 4). 
8.  Particular conditions proposed to be taken into account to manage the risk(s) identified 
  Mitigation measures comparable to no-spray buffer zones up to 20 m were necessary for the 
formulated product to protect aquatic organisms. (see section 5). 
9.  Concerns 
9.1.  Issues that could not be finalised 
An issue is listed as an issue that could not be finalised where there is not enough information 
available to perform an assessment, even at the lowest tier level, for the representative uses in line 
with the Uniform Principles of Annex VI to Directive 91/414/EEC and where the issue is of such 
importance that it could, when finalised, become a concern (which would also be listed as a critical 
area of concern if it is of relevance to all representative uses). 
1.  Groundwater exposure and relevance assessment for the aged column leachate metabolite S5. 
9.2.  Critical areas of concern 
An issue is listed as a critical area of concern where there is enough information available to perform 
an assessment for the representative uses in line with the Uniform Principles of Annex VI to Directive 
91/414/EEC, and where this assessment does not permit to conclude that for at least one of the 
representative uses it may be expected that a plant protection product containing the active substance 
will not have any harmful effect on human or animal health or on groundwater or any unacceptable 
influence on the environment.   
An issue is also listed as a critical area of concern where the assessment at a higher tier level could not 
be finalised due to a lack of information, and where the assessment performed at the lower tier level 
does not permit to conclude that for at least one of the representative uses it may be expected that a 
plant protection product containing the active substance will not have any harmful effect on human or 
animal health or on groundwater or any unacceptable influence on the environment. 
2.  The compliance of the batches tested in the mammalian toxicology and ecotoxicology data 
packages with the proposed specification could not be demonstrated. 
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9.3.  Overview of the concerns identified for each representative use considered 
(If a particular condition proposed to be taken into account to manage an identified risk, as listed in 
section 8, has been evaluated as being effective, then ‘risk identified’ is not indicated in this table.) 
In addition to the specific issue indicated, the column is grey as the technical material specification 
proposed was not demonstrated to be comparable to the material used in the testing that was used to 
derive the toxicological and ecotoxicological reference values. 
Representative use  Grapes 
Operator risk 
Risk identified   
Assessment not finalised   
Worker risk 
Risk identified   
Assessment not finalised   
Bystander risk 
Risk identified   
Assessment not finalised   
Consumer risk 
Risk identified   
Assessment not finalised   
Risk to wild non 
target terrestrial 
vertebrates 
Risk identified   
Assessment not finalised   
Risk to wild non 
target terrestrial 
organisms other 
than vertebrates 
Risk identified   
Assessment not finalised   
Risk to aquatic 
organisms 
Risk identified   
Assessment not finalised   
Groundwater 
exposure active 
substance 
Legal parametric value breached   
Assessment not finalised   
Groundwater 
exposure 
metabolites 
Legal parametric value breached   
Parametric value of 10µg/L
(a) breached   
Assessment not finalised  X
1 
Comments/Remarks   
The superscript numbers in this table relate to the numbered points indicated in sections 9.1 and 9.2.  Where there is no 
superscript number see sections 2 to 6 for further information. 
(a):  Value for non-relevant metabolites prescribed in SANCO/221/2000-rev 10-final, European Commission, 2003 Peer review of the pesticide risk assessment of the active substance valifenalate
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APPENDICES 
APPENDIX A – LIST OF END POINTS FOR THE ACTIVE SUBSTANCE AND THE REPRESENTATIVE 
FORMULATION 
Identity, Physical and Chemical Properties, Details of Uses, Further Information  
 
Active substance (ISO Common Name)   Valifenalate (ISO proposed) 
Function (e.g. fungicide)  Fungicide 
Rapporteur Member State  Hungary 
Co-rapporteur Member State  None 
 
Identity (Annex IIA, point 1) 
 
Chemical name (IUPAC)  methyl N-(isopropoxycarbonyl)-L-valyl-
(3RS)-3-(4-chlorophenyl)-β-alaninate 
Chemical name (CA)  methyl N-[(1-methylethoxy)carbonyl]-L-
valyl-3-(4-chlorophenyl)-β-alaninate 
CIPAC No  857 
CAS No  283159-90-0 
EEC No (EINECS or ELINCS)  Not available 
FAO Specification (including year of 
publication)  Not available 
Minimum purity of the active substance as 
manufactured (g/kg)  980 
Identity of relevant impurities (of 
toxicological, environmental and/or other 
significance) in the active substance as 
manufactured (g/kg) 
No impurities of toxicological or 
environmental significance 
Molecular formula  C19H27ClN2O5 
Molecular mass  398.89 g/mol 
Structural formula 
 
 
 
 
 
 
C H3
CH3
O
O
NH
C H3 CH3
O
NH
O
O
Cl
CH3
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Physical and chemical properties (Annex IIA, point 2) 
 
Melting point (state purity) ‡  147 °C (99.6 %) at 101.74 kPa 
Boiling point (state purity) ‡  367 ± 0.5 °C (99.6 %) at 101.83 to 102.16 kPa 
with minor decomposition 
Temperature of decomposition   Not required 
Appearance ‡  Purified a.s. white, opaque solid in the form of a 
fine, free-flowing powder, odourless   (99.6%). 
 
Technical a.s. (98.36%) white, fine powder, 
with a tendency to form clumps, weak, 
characteristic hint of antiseptic. 
Surface tension 
66.0 mN/m (1.89 x 10
-2 g/l solution) at 20°C ± 
0.5 °C (IR 5885 technical material 98.36%)  
The test material is considered not to be a 
surface active material 
Vapour pressure  ‡ 
9.6 x 10
-8 Pa at 20ºC;   
2.3 x 10
-7 Pa at 25ºC (99.6%) 
Henry’s law constant ‡  1.6 x 10
-6 Pa m
3mol
-1 (calculated at 20°C and 
pH 5.4 ± 0.5) 
Solubility in water  ‡ 
From the predicted dissociation constants was 
seen that ionisation, and therefore solubility, 
may alter under basic conditions: the water 
solubility was performed under basic and 
ambient pH (99.6 %) 
At ambient conditions (pH): 
2.41 x 10
-2 g/L measured pH: 4.9 to 5.9 
At basic pH: 
4.55 x 10
-2 g/L pH: 9.5 to 9.8 
Solubility in organic solvents ‡ 
Solubility in g/L at 20 ± 0.5°C (98.36%) 
heptane: 2.55 x 10
-2 
xylene: 2.31 
acetone: 29.3 
ethyl acetate: 25.4 
1,2-dichloroethane: 14.4 
methanol: 28.8 
Partition co-efficient ‡ 
pH  4 
I°  3.07 ± 0.03; II°  3.04 ± 0.02 
pH 7 
I°  3.11 ± 0.07; II°  3.05 ± 0.03 Peer review of the pesticide risk assessment of the active substance valifenalate
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pH  9 
I°  3.08 ± 0.02; II°  3.06 ± 0.03 
(99.6 %) 
Dissociation constant 
Amide group 1: pKa -1.78 ± 0.70 proton 
accepted 
pKa 11.35 ± 0.46 proton 
donated 
Amide group 2: pKa -1.08 ± 0.70 proton 
accepted 
pKa 14.88 ± 0.46 proton donated 
(99.6%) 
UV/VIS absorption (max.) incl.  ‡  
 
max < 240 nm (221 nm) 
No absorption at   290 nm ( <10) (99.6%) 
Flammability ‡   Not flammable (98.36%) 
Explosive properties ‡  
Not thermally sensitive 
Not shock sensitive 
Not sensitive to friction (98.36%) 
Oxidising properties ‡   Not oxidising (98.36%) 
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Summary of representative uses evaluated VALIFENALATE IR5885 for JAVA F 
 
 
Crop and/or 
situation 
 
 
(a) 
Member 
State, 
Country or 
Region 
 
Product 
Name 
F 
G 
or 
I 
 
 
 
(b) 
 
Pests or Group 
of pests 
controlled 
 
 
 
(c) 
 
Preparation 
 
Application 
 
Application rate per 
treatment 
 
PHI 
(days) 
 
Remarks 
Type
 
 
 
(d-f)
Conc. of 
a.s. 
 
 
(i) 
Method
Kind
 
 
(f-h) 
Growth 
stage & 
season 
 
(j) 
Number
min- 
max 
  
(k) 
Interval
between 
apps. 
(min)  
g a.s./hL
min-max
 
(l) 
water
(L/ha) 
min-max
g a.s./ha
min-max
 
(l) 
 
 
 
 
(m) 
 
 
 
 
Grapes  South and 
North 
Europe 
JAVA F 
(IR5885 F) 
F  Plasmopara 
viticola 
vine downy 
mildew 
 
WG 6% 
valifenalate
+48 % 
folpet 
Spray-
ing 
BBCH 
55-
BBCH 
81 
2-3 10  9.0-12.0
+ 
72.0-
96.0 
 
1000 90-120 
+ 720-
960 
 
 
42  
 
  For uses where the column "Remarks" is marked in grey further consideration is necessary. 
Uses should be crossed out when the notifier no longer supports this use(s). 
(a)  For crops, the EU and Codex classifications (both) should be taken into account; where relevant, the use 
situation should be described (e.g. fumigation of a structure) 
(b)  Outdoor or field use (F), greenhouse application (G) or indoor application (I) 
(c) e.g. biting and suckling insects, soil born insects, foliar fungi, weeds 
(d)  e.g. wettable powder (WP), emulsifiable concentrate (EC), granule (GR) 
(e)  GCPF Codes - GIFAP Technical Monograph No 2, 1989 
(f) All  abbreviations  used must be explained 
(g)  Method, e.g. high volume spraying, low volume spraying, spreading, dusting, drench 
(h) Kind,  e.g. overall, broadcast, aerial spraying, row, individual plant, between the plant- type of equipment 
used must be indicated 
(i)  g/kg or g/L. Normally the rate should be given for the active substance (according to ISO) and not for the 
variant in order to compare the rate for same active substances used in different variants . In certain cases, 
where only one variant is synthesised, it is more appropriate to give the rate for the variant 
 (j)  Growth stage at last treatment (BBCH Monograph, Growth Stages of Plants, 1997, Blackwell, ISBN 3-
8263-3152-4), including where relevant, information on season at time of application 
(k)  Indicate the minimum and maximum number of application possible under practical conditions of use 
(l)  The values should be given in g or kg whatever gives the more manageable number (e.g. 200 kg/ha instead 
of 200 000 g/ha or 12.5 g/ha instead of 0.0125 kg/ha 
(m)  PHI - minimum pre-harvest interval 
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Methods of Analysis 
 
Analytical methods for the active substance (Annex IIA, point 4.1) 
 
Technical as (principle of method)  HPLC with UV-DAD method 
Impurities in technical as (principle of 
method) 
Reversed phase HPLC with UV-DAD at 225 
nm. 
Plant protection product (principle of 
method)  HPLC with UV-DAD detector method 
 
Analytical methods for residues (Annex IIA, point 4.2) 
 
Residue definitions for monitoring purposes 
 
Food of plant origin  Valifenalate (IR 5885) 
Food of animal origin  Valifenalate (IR 5885), IR 5839 
Soil  Valifenalate (IR 5885), IR 5839, PCBA 
Water  surface   Valifenalate (IR 5885), IR 5839, PCBA 
  drinking/ground   Valifenalate (IR 5885), IR 5839, PCBA 
Air  Valifenalate (IR 5885) 
 
Monitoring/Enforcement methods 
 
Food/feed of plant origin (principle of 
method and LOQ for methods for 
monitoring purposes) 
Valifenalate (IR5885): LOQ: 0.01 mg/kg,  
 
Enforcement method validated in grapes and 
wine: HPLC-MS/MS;  
Enforcement method (including validation) 
for potatoes HPLC-MS/MS;  
Enforcement method validated in grape 
bunches and raisins HPLC-MS/MS; 
 
ILV in potatoes, grape bunches and vine 
HPLC-MS;  
ILV in grape, tomato, tomato paste, grape 
juice and raisins HPLC-MS/MS Peer review of the pesticide risk assessment of the active substance valifenalate
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Food/feed of animal origin (principle of 
method and LOQ for methods for 
monitoring purposes) 
Not applicable 
Soil (principle of method and LOQ) 
Valifenalate (IR5885): HPLC-MS/MS. LOQ : 
0.05mg/kg +validation with additional mass 
transition ion (re-calculation) 
IR5839: HPLC-MS. LOQ : 0.05mg/kg + 
validation with additional mass transition ion 
(re-calculation) 
PCBA: HRGC/ECD. LOQ : 0.05 mg/kg 
Water (principle of method and LOQ) 
Valifenalate (IR5885) in ground/drinking 
water: HPLC-MS/MS. LOQ : 0.1 g/L + 
confirmatory re-calculation with additional 
mass transition ion 
IR 5839 in ground/drinking water: HPLC-
MS. LOQ : 0.1 g/L + validation with 
additional mass transition ion (re-calculation) 
PCBA in ground/drinking water: 
HRGC/ECD. LOQ : 0.1 g/L 
Valifenalate (IR 5885) in surface water: LC-
MS LOQ : 10 g/L + confirmatory re-
calculation with additional mass transition ion 
IR 5839 in surface water: HPLC-MS/MS. 
LOQ : 10 g/L + validation with additional 
mass transition ion (re-calculation) 
PCBA in surface water: HRGC/ECD. LOQ : 
10 g/L. 
Air (principle of method and LOQ) 
The method was based on the analysis of 
valifenalate using HPLC with MS/MS 
detection. 
LOQ for air :  0.104 µg/m
3 
Body fluids and tissues (principle of method 
and LOQ) 
Valifenalate (IR5885) in milk and biological 
tissues: HPLC-MS.  LOQ : 0.02mg/kg  
 
Classification and proposed labelling with regard to physical and chemical data (Annex 
IIA, point 10) 
 
  RMS/peer review proposal 
Active substance  No classification required 
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Impact on Human and Animal Health 
 
 
Absorption, distribution, excretion and metabolism (toxicokinetics) (Annex IIA, point 
5.1) 
Rate and extent of oral absorption ‡  About 80% based on urinary (12.84% in males, 
30.79% in females) and biliary (64.55% in 
males, 48.68% in females) excretion within 48 
hours 
Distribution  ‡  Widely distributed; highest residues in liver 
and kidneys at one or two hours after 
administration 
Potential for accumulation ‡  No evidence for accumulation 
Rate and extent of excretion ‡  Rapid and extensive (approx. 99%) within 48 
hours, mainly via bile (64.55% in males, 
48.68% in females), urine (12.84% in males, 
30.79% in females) and faeces (16.63% in 
males, 15.55% in females) 
Metabolism in animals ‡  Extensively metabolised (>90%); main 
metabolites R2 (N-[(1-methylethoxy)carbonyl]-
L-valyl-3-(4-chlorophenyl)) and R5 (3-amino-
3-(4-chlorophenyl) propionic acid); oxidation 
reactions and cleavage reaction 
Toxicologically relevant compounds ‡
(animals and plants)  Valifenalate 
Toxicologically relevant compounds ‡
(environment)  none 
 
 
Acute toxicity (Annex IIA, point 5.2) 
Rat LD50 oral ‡  > 5000 mg/kg bw  - 
Rat LD50 dermal ‡  > 2000 mg/kg bw  - 
Rat LC50 inhalation ‡  > 3.118 mg/l  - 
Skin irritation ‡  Non-irritant  - 
Eye irritation ‡  Non-irritant  - 
Skin sensitisation ‡  Non -sensitising (Magnusson and 
Kligman) 
- 
 
 
Short term toxicity (Annex IIA, point 5.3) 
Target / critical effect ‡  liver: increased weight, hepatocyte vacuolation 
(mouse); hepatocyte hypertrophy, 
cytoplasmatic inclusion (dog) 
Relevant oral NOAEL ‡  90-day mouse: 15.3 mg/kg bw per day 
(males)  
90-day rat: 150 mg/kg bw per day  
90-day dog:  <50 mg/kg bw per day (No 
NOAEL can be 
established) 
- Peer review of the pesticide risk assessment of the active substance valifenalate
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1-year dog: 7 mg/kg bw per day  
Relevant dermal NOAEL ‡  28-day rat: 1000 mg/kg bw per day   - 
Relevant inhalation NOAEL ‡  No data- not required  - 
 
 
Genotoxicity ‡ (Annex IIA, point 5.4) 
  Substance is unlikely to be genotoxic  - 
 
 
Long term toxicity and carcinogenicity (Annex IIA, point 5.5) 
Target/critical effect ‡  2-year, Rat, thyroid glands and kidneys  
78-week, Mouse, liver, increased incidence of 
hepatocellular tumours both in males and 
females 
Relevant NOAEL ‡  150 mg/kg bw per day ; 2-year, rat 
16.8 mg/kg bw per day ; 78-week, mouse 
Carcinogenicity ‡  No carcinogenic potential in rat. Liver 
tumours in mice might be relevant for 
humans  
R40 
 
 
Reproductive toxicity (Annex IIA, point 5.6) 
Reproduction toxicity 
Reproduction target / critical effect ‡  Increased number of dead pups at first 
litter check and decreased viability 
index recorded in F1 generation 
- 
Relevant parental NOAEL ‡  80-100 mg/kg bw per day   - 
Relevant reproductive NOAEL ‡  80-100 mg/kg bw per day   - 
Relevant offspring NOAEL ‡  80-100 mg/kg bw per day   - 
 
Developmental toxicity  
Developmental target / critical effect ‡  Slightly higher mean bodyweight gain 
in mothers, no foetal effects. 
- 
Relevant maternal NOAEL ‡  rat: 1000 mg/kg bw per day  
rabbit: 1000 mg/kg bw per day  
- 
Relevant developmental NOAEL ‡  rat: 1000 mg/kg bw per day  
rabbit: 1000 mg/kg bw per day  
- 
 
 
Neurotoxicity (Annex IIA, point 5.7) 
Acute neurotoxicity ‡  No data, not required  - 
Repeated neurotoxicity ‡  No data, not required  - 
Delayed neurotoxicity ‡  No data, not required  - 
 
 
Other toxicological studies (Annex IIA, point 5.8) 
Mechanism studies ‡  no data- not required Peer review of the pesticide risk assessment of the active substance valifenalate
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Studies performed on metabolites or 
impurities ‡ 
                                                                
IR5839 
 
Rat LD50 oral of metabolite IR5839 > 2000 
mg/kg bw 
Genotoxicity of metabolite IR5839   
No genotoxic potential 
                                                                 
PCBA 
Rat LD50 oral of metabolite PCBA   1170 mg/kg 
bw  
Genotoxicity of metabolite PCBA  
No genotoxic potential 
 
 
Medical data ‡ (Annex IIA, point 5.9) 
  No information available, IR5885 is a new 
active substance not yet produced at large scale 
level. 
No clinical cases or poisoning incidents have 
been recorded at pilot plant production level or 
between the personnel that manipulated the 
product during the experimental studies. 
 
 
Summary (Annex IIA, point 5.10)  Value Study  Safety 
factor 
ADI ‡   
0.07 mg/kg bw 
per day  
dog, 1 year  100 
AOEL ‡   
0.07 mg/kg bw 
per day  
dog, 1 year  100 
ARfD ‡  Not allocated-
not necessary  - - 
 
 
Dermal absorption ‡ (Annex IIIA, point 7.3) 
JAVA F (Valifenalate 6%, Folpet 48%, 
WG) 
Concentrate: 20% 
Spray dilution: 4% 
Rabbit, in vivo 
 
 
Exposure scenarios (Annex IIIA, point 7.2)  
Operator  Tractor mounted equipment 
without PPE  
UK POEM: 65%  
German model: 17%  
Handheld  equipment without PPE 
UK POEM: 107% (3% with gloves and 
coverall) 
German model: 15%  
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Workers 12%   
Bystanders 0.15%   
 
 
Classification and proposed labelling with regard to toxicological data (Annex IIA, 
point 10) 
  RMS/peer review proposal  
Valifenalate  H 351 Suspected of causing cancer 
R 40 Limited evidence of a carcinogenic effect. 
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Residues 
 
Metabolism in plants (Annex IIA, point 6.1 and 6.7, Annex IIIA, point 8.1 and 8.6) 
 
Plant groups covered  Grapes, potato, 
tomato, lettuce 
Rotational crops  Not relevant 
Metabolism in rotational crops similar to metabolism in primary 
crops 
Not relevant 
Processed  commodities  Grapes, juice, wine, 
wet pomace 
Residue pattern in processed commodities similar to residue pattern 
in raw commodities 
Yes 
Plant residue definition for monitoring  Valifenalate 
Plant residue definition for risk assessment  Valifenalate 
Conversion factor (monitoring to risk assessment)  None 
 
Metabolism in livestock (Annex IIA, point 6.2 and 6.7, Annex IIIA, point 8.1 and 8.6) 
 
Animals covered  Lactating Goat 
Time needed to reach a plateau 
concentration in milk and eggs  8 hours 
Animal residue definition for monitoring Valifenalate  and  its metabolite IR5839 
 
Animal residue definition for risk 
assessment 
Valifenalate and its metabolite IR5839 
 
Conversion factor (monitoring to risk 
assessment)  Not relevant 
Metabolism in rat and ruminant similar 
(yes/no) 
Lactating goat: the major route of excretion was 
via faeces, with 68.19% of the total 
administered dose. Recovery radioactivity in the 
urine and cage wash accounted for 12.54% and 
2.40%, respectively. Concentrations of 
radioactivity in milk were low. The highest 
tissue residue levels were found in liver and 
kidneys. Very low concentrations in muscle. 
Overall, the recovery of total radioactivity in 
urine, faeces, milk, cage wash and edible tissues 
accounted for 98.04% of the total administered 
dose. 
Fat soluble residue: (yes/no)  No 
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Residues in succeeding crops (Annex IIA, point 6.6, Annex IIIA, point 8.5) 
 
 Not  relevant 
 
Stability of residues (Annex IIA, point 6 introduction, Annex IIIA, point 8 Introduction) 
 
 
Valifenalate and its metabolite IR5839 remain 
substantially unchanged over a 2 year- period in 
all examined substrates. 
 
 
Residues from livestock feeding studies (Annex IIA, point 6.4, Annex IIIA, point 8.3) 
 
Intakes by livestock  0.1 mg/kg/diet/day 
Ruminant: 
no 
Poultry: 
no 
Pig: 
no 
Muscle -  -  - 
Liver -  -  - 
Kidney -  -  - 
Fat -  -  - 
Milk -  -  - 
Eggs -  -  - 
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Summary of critical residues data (Annex IIA, point 6.3 and Annex IIIA, point 8.2) 
 
 
Commodity Region 
(a) 
Outdoor
/Indoor 
Individual trial results (mg/kg)  STMR  
(mg/kg)
 (b) 
HR 
(mg/kg) 
(c) 
Rmax& Rber& 
OECD MRL 
Calc   
MRL 
proposal 
(mg/kg) 
Median 
CF 
(d) 
Comments 
Enforcement Risk  assessment 
  Enforcement residue definition: Valifenalate (IR5885) 
Risk assessment residue definition: Valifenalate (IR5885) 
Grape NEU  Outdoor  0.040,  0.044, 
0.045, 0.058, 
0.059, 0.073, 
0.073, 0.084 
0.040, 0.044, 
0.045, 0.058, 
0.059, 0.073, 
0.073, 0.084 
0.059 0.084  R(max)=   
0.111 
R(ber) =  
0.146 
MRL Calc= 
0.2 
0.2 -  - 
SEU Outdoor  0.016,  0.019, 
0.020, 0.037, 
0.039, 0.044, 
0.052, 0.062 
0.016, 0.019, 
0.020, 0.037, 
0.039, 0.044, 
0.052, 0.062 
0.038 0.062  R(max)=   
0.090 
R(ber) =  
0.1 
MRL Calc= 
0.15 
0.15 -  - 
 
(a):  NEU, SEU, EU or Import (country code). In the case of indoor uses there is no necessity to differentiate between NEU and SEU. 
(b):  Median value of the individual trial results according to the enforcement residue definition. 
(c):  Highest value of the individual trial results according to the enforcement residue definition. 
(d):  The median conversion factor for enforcement to risk assessment is obtained by calculating the median of the individual conversion factors for each residues trial 
 Peer review of the pesticide risk assessment of the active substance valifenalate
 
EFSA Journal 2013;11(6):3253    29
 
Consumer risk assessment (Annex IIA, point 6.9, Annex IIIA, point 8.8)
7 
 
ADI   0.07 
TMDI (% ADI) according to EFSA 
PRIMo rev.2.0 
0.3 - 1.7% ADI 
TMDI (% ADI) according to national (to 
be specified) diets 
- 
IEDI (WHO European Diet) (% ADI)  - 
NEDI (specify diet) (% ADI)  Not relevant 
Factors included in IEDI and NEDI  Not relevant 
ARfD  Not relevant on the basis of the acute 
toxicological profile 
IESTI (% ARfD)  Not relevant 
NESTI (% ARfD) according to national 
(to be specified) large portion 
consumption data 
- 
Factors included in IESTI and NESTI   - 
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Processing factors (Annex IIA, point 6.5, Annex IIIA, point 8.4) 
 
Wine 
Crop/ process/ processed product 
 
Number of 
studies 
Processing factors  Amount 
transferred 
(%) 
(Optional) 
Transfer 
factor 
8 
Yield 
factor 
8 
Bunches – Wet pomace  7  1.13–4.35 
median 
PF= 2.23
  
Bunches - Must  7  0.68–1.76 
median 
PF= 0.77
8,9 
8 
Bunches – Young wine - White  7  0.53-1.32 
median 
PF= 0.57 
  
Red 7  0.37-0.89 
median 
PF= 0.76 
  
Bunches – Bottled wine- White   7   
0.27-1.32 
median 
PF= 0.50 
  
Red 7  0.23-0.94 
median 
PF= 0.71 
  
 
Juice 
Crop/ process/ processed product 
 
Number of 
studies 
Processing factors  Amount 
transferred 
(%) 
(Optional) 
Transfer 
factor 
8 
Yield 
factor 
8 
Bunches – Wet pomace  5  1.03–2.51 
median 
PF= 2.1
  
Bunches - Sediment  5  0.53–0.88 
median 
PF= 0.73
8,9 8 
Bunches – Juice  10  0.26-0.77 
median 
PF= 0.51
  
8 See separate examples at the beginning of the section 
9 Mention whether case B1 or case B2 
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Proposed MRLs (Annex IIA, point 6.7 and Annex IIIA, point 8.6) 
 
Proposed MRLs  Grapes 0.2 mg/kg 
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Fate and behaviour in the environment 
 
Route of degradation (aerobic) in soil (Annex IIA, point 7.1.1.1.1) 
 
Mineralization after 100 days 
 
14C-valifenalate, evolved CO2 :  
 
22.74 % in SP-2.2 (48 hours) 
26.00 % in SP-3A (48 hours) 
17.55 % in VM-1 (48 hours) 
26.96 % in SP-2.3 (96 hours) 
 
Non-extractable residues after 100 days 
 
14C-IR5885, bound residue :  
 
26.41 % in SP-2.2 (48 hours) 
27.68 % in SP-3A (48 hours) 
23.98 % in VM-1 (48 hours) 
24.99 % in SP-2.3 (96 hours) 
 
Relevant metabolites - name and/or code, 
% of applied (range and maximum) 
IR5839: 
range 46.45 % to 75.34% (n = 4) 
 
PCBA: 
range 36.04% to 50.21% (n = 4) 
 
Route of degradation in soil - Supplemental studies (Annex IIA, point 7.1.1.1.2) 
 
Anaerobic degradation 
  Not relevant 
Soil photolysis 
 
VM-1 soil 
irradiated wet soil, DT50lab:           37 days 
irradiated dry soil, DT50lab:      458 days 
not irradiated wet soil, DT50lab:  21 days 
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Rate of degradation in soil (Annex IIA, point 7.1.1.2, Annex IIIA, point 9.1.1) 
 
 
 
IR-5839  Aerobic conditions 
Soil type  
 
pH t. 
oC/ % 
MWHC 
DT50/ DT90 
(d)  
 f.  f.  
kdp/k
f 
DT50 (d) 
20C 
pF2/10kPa  
St. 
(
2)
 
Method of 
calculation 
Sandy loam SP-2.3  6.5  20
oC /40 % 0.63/2.09  1  0.63  5.8%  SFO 
Loamy sand SP- 2.2  5.8  20
oC /40 % 0.63/2.1  1  0.63  2.1%  FOMC 
Loam SP-3 A  7.1  20
oC /40 % 0.32/1.06  1  0.32  9.0%  SFO 
Silty clay loam VM-1  7.48  20
oC / 40% 0.30/0.99  1  0.30  8.4%  SFO 
Geometric mean     0.44    
 
PCBA  Aerobic conditions 
Soil type  
 
pH t. 
oC/ % 
MWHC 
DT50/ DT90 
(d)  
 f. f.    
kdp/kf 
DT50 (d) 
20C 
pF2/10kPa  
St. 
(
2)
 
Method of 
calculation 
Sandy loam SP-2.3  6.5  20
oC / 40%  2.53/8.41  0.75  2.53  9.6%  SFO 
Loamy sand SP- 2.2  5.8  20
oC / 40%  9.52*/31.6
0 
0.57 9.52  11.4%  FOMC 
Loam SP-3 A  7.1  20
oC / 40%  2.00/6.50  0.62  2.00  16.4%  SFO 
Silty clay loam VM-1  7.48  20
oC / 40%  2.30/7.5  0.77  2.30  5.8%  SFO 
Geometric mean    0.68** 3.24    
*calculated by DT90/3.32 
**arithmetic mean 
 
Soil adsorption/desorption (Annex IIA, point 7.1.2) 
 
valifenalate 
Soil Type  OC%  Soil pH  Kd 
(mL/g) 
Koc 
(mL/g) 
Kf 
(mL/g) 
Kfoc 
(mL/g) 
1/n 
       
Loamy sand  14.42  3.38  54  375  73  506  0.998 
Clay 0.89  7.55  15 1686  19 2134  1.169 
Clay 1.80  5.6  9  472  9  500  0.955 
Loam 2.13  5.16  9  400  8  375  1.038 
Sand 0.90  5.2  8  834  7  777  1.031 
Arithmetic mean/median  23.2  859  1.038 
Laboratory studies 
valifenalate  Aerobic conditions 
Soil type  pH  t. 
oC/ % 
MWHC 
DT50 /DT90 
(d)  
DT50 (d) 
20C 
pF2/10kPa 
St. 
(
2  
Method of 
calculation 
Sandy loam SP-2.3  6.5  20
oC / 40%  0.37/1.22  0.37  4.1%  SFO 
Loamy sand SP- 2.2  5.8 20
oC / 40%  0.06/0.19  0.06  5.4%  FOMC 
Loam SP-3 A  7.1  20
oC / 40%  0.14/0.46  0.14  8.3%  SFO 
Silty clay loam VM-1  7.48  20
oC / 40%  0.15/0.58  0.15  4.9%  SFO 
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pH dependence, Yes or No  No 
 
IR5839 
Soil Type  OC %  Soil pH  Kd 
(mL/g)
Koc 
(mL/g)
Kf 
(mL/g) 
Kfoc 
(mL/g) 
1/n 
Loamy sand  14.42  3.24  16.87  120  13.74  95.28  0.919 
Clay 0.89  7.60  0.69  58  0.648  72.81  0.971 
Loam 2.13  5.08  0.48  24  0.731  34.32  0.972 
Arithmetic mean/median   5.0  67.47  0.954 
pH dependence (yes or no)  Yes 
 
PCBA 
Soil Type  OC %  Soil pH  Kd 
(mL/g)
Koc 
(mL/g)
Kf 
(mL/g) 
Kfoc 
(mL/g) 
1/n 
Loamy sand  14.42  3.24  41.51  296.5  38.26  265.33  0.995 
Clay 0.89  7.60  0.23  19.14  0.24  26.97  0.931 
Loam 2.13  5.08  2.81  139.72 2.19  102.82  0.994 
Arithmetic mean/median     131.7  0.973 
pH dependence (yes or no)  Yes 
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Mobility in soil (Annex IIA, point 7.1.3, Annex IIIA, point 9.1.2) 
 
Column leaching  Not data available, not required 
Aged residues leaching 
 
Two German standard soils: SP-2.2 (loamy 
sand) and SP-2.3 (sandy loam).  
valifenalate: 40.82% AR in SP-2.2 and 45.84% 
AR in SP-2.3.  
IR5839: 57.37% AR in SP-2.2 and 36.49% AR 
in SP-2.3. 
The radioactivity found in leachates amounted 
to 23.76 AR in SP-2.2 and 34.07% in SP-2.3.  
S2 (IR5839) was the main component with 
21.78% in SP-2.2 and 24.76% in SP-2.3 soil 
respectively. A metabolite named S5 was 
observed to reach levels up to 5 % AR and up 
to 1.5 g / L in the leachate. A data gap has 
been identified for its assessment with respect 
to potential groundwater contamination.  
The radioactivity extracted from soil segments 
accounted for 45.81% and 42.38% AR is SP-
2.2 and SP-2.3 respectively. The main 
compounds were S2 (IR5839) and S3. 
valifenalate accounted for 0.87% in SP-2.2 and 
2.38% AR in SP-2.3. The compound S2 
(IR5839) accounted for 20.18% in SP-2.2 and 
3.50% AR in SP-2.3 soil, while S3 accounted 
for 16.06% and 28.89% AR. 
Lysimeter/ field leaching studies 
  No data available, not required.  
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PEC (soil) (Annex IIIA, point 9.1.3) 
 
Method of calculation – input data  Standard assumption: soil bulk density 1.5 kg/L, 
5 cm soil layer 
 
valifenalate: 
DT50: 0.5 days 
MW: 398.89 
 
IR5839: 
DT50: 0.69 days  
MW: 384.85 
%ARmetab (from soil degradation study with parent 
comp.): 75.34 
 
PCBA: 
DT50: 3.24 days  
MW: 156.57 
%ARmetab (from soil degradation study with parent 
comp.): 50.21 
 
First-order kinetics 
 
The worst case, Southern Europe regions, was 
considered 
Application rate  Crop: Vineyards 
Plant interception: 60%  
Number of applications: 3 
Interval: 10 days 
Application rate: 120 g as/ha  
 
Scenario grape South EU - PECs of valifenalate and its metabolites after 1 treatment –– soil 
coverage 60% 
Time after 
last 
application 
(days) 
valifenalate 
metabolites 
IR5839 PCBA 
actual 
(mg/kg) 
TWA 
(mg/kg) 
actual 
(mg/kg) 
TWA 
(mg/kg) 
actual 
(mg/kg) 
TWA 
(mg/kg) 
PECini 0.0640   0.0465  0.0126   
1  0.0160  0.0346 0.0170 0.0294 0.0102  0.0114 
2  0.0040  0.0216 0.0062 0.0200 0.0082  0.0103 
4  0.0003  0.0115 0.0008 0.0114 0.0054  0.0085 
7  0.0000  0.0066 0.0000 0.0066 0.0028  0.0065 
14  0.0000  0.0033 0.0000 0.0033 0.0006  0.0040 
21  0.0000  0.0022 0.0000 0.0022 0.0001  0.0028 
28  0.0000  0.0016 0.0000 0.0017 0.0000  0.0021 
50  0.0000  0.0009 0.0000 0.0009 0.0000  0.0012 
100  0.0000  0.0005 0.0000 0.0005 0.0000  0.0006 
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Scenario grape South EU - PECs of valifenalate and its metabolites after 3 treatments –– soil 
coverage 60% 
 
Time after 
last 
application 
(days) 
valifenalate 
metabolites 
IR5839 PCBA 
actual 
(mg/kg) 
TWA 
(mg/kg) 
actual 
(mg/kg) 
TWA 
(mg/kg) 
actual 
(mg/kg) 
TWA 
(mg/kg) 
PECini  0.0640  0.0465  0.0143   
1  0.0160 0.0346 0.0170 0.0294 0.0115  0.0128 
2  0.0040 0.0216 0.0062 0.0201 0.0093  0.0116 
4  0.0003 0.0115 0.0008 0.0114 0.0061  0.0096 
7  0.0000 0.0066 0.0000 0.0066 0.0032  0.0074 
14  0.0000 0.0033 0.0000 0.0033 0.0007  0.0045 
21  0.0000 0.0022 0.0000 0.0022 0.0002  0.0031 
28  0.0000 0.0016 0.0000 0.0017 0.0000  0.0024 
50  0.0000 0.0009 0.0000 0.0009 0.0000  0.0013 
100  0.0000 0.0005 0.0000 0.0005 0.0000  0.0007 
365  0.0000 0.0001 0.0000 0.0001 0.0000  0.0002 
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PECs of valifenalate and its metabolites used for ecotoxicological risk assessment  
 
compound  PECs for ecotoxicological risk assessment (mg/kg dry soil) 
valifenalate  0.0640 
IR5839 0.0465 
PCBA 0.0143 
 
 
Route and rate of degradation in water (Annex IIA, point 7.2.1) 
Hydrolysis of active substance and 
relevant metabolites (DT50) (state pH and 
temperature)  
valifenalate – pH 4: no significant degradation 
 
IR5839 – pH 4: stable 
 
PCBA –   pH 4: stable 
  valifenalate –  pH 7:  
DT50 = 2.09 days (65ºC)  
DT50 = 5.21 days (55ºC)  
DT50 = 7.62 days (50ºC) 
DT50 = 90.94 days (25ºC) 
a pseudo first order kinetic was observed, two 
main compounds found: unchanged 
valifenalate and IR5839. 
 
IR5839 –  pH 7: stable 
 
PCBA – pH 7: stable 
  valifenalate –  pH 9:  
DT50 = 0.33 days (50ºC)  
DT50 = 4.15 days (25ºC extrapolated - 
Arrhenius) 
a pseudo first order kinetic was observed, two 
main compounds found: unchanged 
valifenalate and IR5839. 
 
IR5839 – pH 9: stable 
 
PCBA – pH 9: stable 
Photolytic degradation of active 
substance and relevant metabolites 
 
Not performed as no absorption at wave 
lengths > 290 nm (IR5885 and metabolites) 
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Degradation in          - DT50 surface water 
water/sediment         - DT90 surface water 
 
                               - DT50 whole system 
                               - DT90 whole system 
 
Values calculated were no reliable.  
 
 
 
4.5 days (pond) and 4.71 days (river) 
14.9 days (Pond) and 15.64 days (River) 
 
 
Distribution in water / sediment systems 
(active substance) 
Surface water - The radioactivity: 40.84% AR 
(Pond) and 43.74% AR (River).  
Sediment - The radioactivity increased: 50.64% 
AR (Pond) and 45.51% AR (River).  
In both aquatic systems - IR5885 degraded 
after 22: 5.92% AR (Pond) and 5.51% AR 
(River).  
Distribution in water / sediment systems 
(metabolites) 
The main degradation compounds out of eight 
found in the water sediment degradation study 
were S2 (IR5839) and S3 (PCBA).  
IR5839: 52.80% AR (Pond) and 56.34% AR 
(River).  
PCBA: 13.77% AR (Pond) and 8.16% AR 
(River). 
 
Degradation in water / sediment 
Parent 
valifenalate 
Distribution (Max  in water 101%  at 0 d. Max. sed 1.79% after 1 d) 
Water / sediment 
system 
pH 
water 
phase   
pH sed  t. 
(
oC) 
DT50-DT90 
whole sys. 
St. 
(r
2) 
DT50 
water 
St. 
(r
2) 
DT50 
sed 
St. 
(r
2)
 
Method of 
calculation 
River 6.97-
7.36 
6.65-
7.25 
20 4.71    1000
a -  4.71
a -  Conservative 
approach 
Pond 5.88-
6.86 
6.07-
6.27 
20 4.50    1000
a -  4.50
a -  Conservative 
approach 
Geometric mean/median       1000   4.60    
a) Assumed for modelling according FOCUS 2006 
 
Metabolite 
IR5839 
Distribution (Max in water 44.03% after 14 d. Max. sed 26.03% after 22 d) 
Water / sediment 
system 
pH 
water 
phase 
pH sed  t. 
(
oC)  
DT50-DT90 
whole sys. 
St. 
(r
2)
DT50 
water 
r
2 DT50 
sed 
St. 
(r
2)
 
Method of 
calculation 
River 6.97-
7.36 
6.65-
7.25 
20  24.65   1000
b   24.65
b   Conservative 
approach 
Pond 5.88- 
6.86 
6.07-
6.27 
20  26.65   1000
b   26.65
b   Conservative 
approach 
Geometric mean/median    -   1000   25.63    
b) Assumed for modelling according FOCUS 2006 
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Metabolite 
PCBA 
Distribution (eg. max in water 12.18%  after 14 d. Max. sed 1.59% after 14 d) 
Water / sediment 
system 
pH 
water 
phase 
pH 
sed 
t. 
(
oC)  
DT50-DT90 
whole sys. 
St. 
(r
2)
DT50 
water 
r
2 DT50 
sed 
St. 
(r
2)
 
Method of 
calculation 
River 6.97-
7.36 
6.65-
7.25 
20   
 
9.52 
 1000
c    
9.52
c 
 Conservative 
approach 
Pond 5.88-
6.86 
6.07-
6.27 
20   1000
c     Conservative 
approach 
Geometric mean/median    -   1000   9.52   
c) Assumed for modelling according FOCUS 2006 
 
 
Mineralization and non extractable residues 
Water / sediment 
system 
pH 
water 
phase 
pH sed  Mineralization  
x% after 22 d. (end 
of the study). 
Non-extractable 
residues in sed. max x 
% after 22 d 
Non-extractable residues in 
sed. max x% after 22 d (end 
of the study) 
River 6.97-
7.36 
6.65-
7.25 
1.24 16.24  16.24 
Pond 5.88-
6.86 
6.07-
6.27 
1.04 8.99  8.99 
 
PEC (surface water) and PEC sediment (Annex IIIA, point 9.2.3) 
 
Method of calculation  Focus surface water model (step 1-2 in focus ver.1.1) with 
standard assumptions for water body sediment: 
 
Input data:  valifenalate  IR5839  PCBA 
Soil DT50 (day) 0.25  0.25*  0.25* 
Mw 398.89  384.85  156.57 
koc (ml/g)  753  753*  753* 
Water sediment 
DT50 whole system (day) 
DT50 water (day) 
Max % metabolite 
 
5.3 
5.3 
- 
 
5.3* 
5.3* 
56.34 
 
5.3* 
5.3* 
13.77 
Water solubility (mg/L)  24  24*  24* 
Max % of metabolite in 
soil (% AR)  - 75.34  50.21 
Application  
rate & conditions 
Crop: vineyards 
Number of applications: 3 
Interval: 10 days 
Crop interception: full canopy – 70% 
Season: June - September  
Region: Southern Europe (worst case) 
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Scenario Grapes, South– EU  PECsw and PECsed for valifenalate  
 
Time 
after max 
peak (d) 
PEC surface water (μg/L)  PEC sediment (μg/kg dry sed) 
single 
application  3 applications  single application 3 applications 
actual  TWA  actual  TWA  actual  TWA  actual  TWA 
0 3.21  - 3.32  - 7.23 - 8.56  - 
1  1.87  2.54 2.11 2.71 6.49 6.85 8.40 8.48 
2  1.50  2.11 1.73 2.32 5.71 6.48 7.50 8.21 
4  1.14  1.71 1.31 1.91 5.50 6.21 7.24 7.60 
7  0.64  1.33 0.74 1.50 3.71 5.50 4.89 6.91 
14  0.25  0.87 0.29 0.99 1.48 3.97 1.95 5.06 
21  0.10  0.64 0.11 0.72 0.59 2.97 0.78 3.80 
28  0.04  0.49 0.04 0.56 0.23 2.32 0.31 2.98 
42  0.00  0.33 0.00 0.38 0.03 1.58 0.05 2.03 
50  0.00  0.28 0.00 0.32 0.01 1.33 0.01 1.71 
100 0.00  0.14 0.00 0.16 0.00 0.67 0.00 0.85 
 
Scenario Grapes, South– EU PECsw and PECsed for the metabolite IR5839  
 
Time 
after max 
peak (d) 
PEC surface water (μg/L)  PEC sediment (μg/kg dry sed) 
single 
application  3 applications  single application 3 applications 
actual  TWA  actual  TWA  actual  TWA  actual  TWA 
0 1.75 - 1.80  - 3.93 - 4.65  - 
1  1.02  1.38 1.14 1.47 3.52 3.72 4.56 4.61 
2  0.82  1.15 0.94 1.26 3.10 3.52 4.07 4.46 
4  0.62  0.93 0.71 1.04 2.99 3.37 3.93 4.13 
7  0.34  0.72 0.40 0.81 2.02 2.99 2.65 3.75 
14  0.13  0.47 0.16 0.53 0.80 2.15 1.06 2.75 
21  0.05  0.34 0.06 0.39 0.32 1.61 0.42 2.06 
28  0.02  0.27 0.02 0.30 0.12 1.26 0.17 1.62 
42  0.00  0.18 0.00 0.20 0.02 0.86 0.02 1.10 
50  0.00  0.15 0.00 0.17 0.00 0.72 0.00 0.93 
100 0.00  0.07 0.00 0.08 0.00 0.36 0.00 0.46 
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Scenario Grapes, South– EU  PECsw and PECsed for the metabolite PCBA 
  
Time 
after max 
peak (d) 
PEC surface water (μg/L)  PEC sediment (μg/kg dry sed) 
single 
application  3 applications  single application 3 applications 
actual  TWA  actual  TWA  actual  TWA  actual  TWA 
0 0.17 - 0.17  - 0.39 - 0.46  - 
1  0.10  0.13 0.11 0.14 0.35 0.37 0.45 0.45 
2  0.08  0.11 0.09 0.12 0.30 0.35 0.40 0.44 
4  0.06  0.09 0.07 0.10 0.29 0.33 0.39 0.41 
7  0.03  0.07 0.04 0.08 0.20 0.29 0.26 0.37 
14  0.01  0.04 0.01 0.05 0.08 0.21 0.10 0.27 
21  0.00  0.03 0.00 0.03 0.03 0.16 0.04 0.20 
28  0.00  0.02 0.00 0.03 0.01 0.12 0.01 0.16 
42  0.00  0.01 0.00 0.02 0.00 0.08 0.00 0.11 
50  0.00  0.01 0.00 0.01 0.00 0.07 0.00 0.09 
100 0.00  0.00 0.00 0.00 0.00 0.03 0.00 0.04 
 
Parent valifenalate 
Parameters used in FOCUSsw Step 3 
Molecular weight (g/mol): 398.88 
Water solubility (mg/L): 24 
Vapour pressure:9.6x10
-8 
KfOC (L/kg): 859 
1/n: 0.96 
DT50 soil (d): 0.15 (Lab)  
DT50 water (d): 1000 
DT50 sediment (d): 4.6 
Application rate  Crop: vine 
Crop interception: 70% 
Number of applications: 3 
Interval (d): 10 
Application rate(s): 120 g as/ha 
Application window: 
D6: 10 Aug - 29 Sep 
R1: 30 Jul -18 Sep 
R2: 30 Jun - 19 Aug 
R3: 01 Aug - 20 Sep 
R4: 20 Jun -09 Aug 
 
PECsw and PECsed values of valifenalate resulted in FOCUS Step 3 calculation 
 
Scenario  PECswini (g/L)  PECsw 28d 
TWA 
(g/L) 
PECsedini 
(g/kg) 
PECsed28d 
TWA 
(g/kg) 
1 applicatiom  3 application 
D6 ditch  2.0580  2.0900  1.1950 1.9950  1.4890 
R1 pond  0.0732  0.1440  0.1170 0.2760  0.2620 
R1 stream  1.5090  1.2870 0.0198 0.1880 0.0418 
R2 stream  2.0230  1.7250 0.0207 0.1340 0.0310 
R3 stream  2.1280  1.8140 0.0734 0.3940 0.0826 
R4 stream  1.50980  1.2870 0.0295 0.1840 0.0443 Peer review of the pesticide risk assessment of the active substance valifenalate
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PECsw of valifenalate and its metabolites used for ecotoxicological risk assessment 
  
compound  PECsw for ecotoxicological risk assessment (g/L) 
valifenalate  3.32 
IR5839 1.80 
PCBA 0.17 
 
PEC SW (initial) for the formulation (based on spray drift only) 
IR5885 F, application rate and PIECsw, 90
th percentile, one treatment (Rautmann, 2001) 
Crop  kg 
product/ha 
PIEC mg/L 
3 m 
(8.02%) 
5 m 
(3.62%) 
10 m 
(1.23%) 
15 m 
(0.65%) 
20 m 
(0.42%) 
30 m 
(0.22%) 
Vineyards  2.0  0.0534 0.0241 0.0082 0.0043 0.0028 0.0014 
 
PEC (ground water) (Annex IIIA, point 9.2.1) 
 
Method of calculation and type of study 
FOCUS PELMO 4.4.3;  
FOCUS PEARL 4.4.4 
Modelling using FOCUS model(s), with 
appropriate FOCUSgw scenarios, according to 
FOCUS guidance. 
Model(s) used: (with version control no.(s)) 
FOCUS PELMO 4.4.3; FOCUS PEARL 4.4.4 
Scenarios (list of names): Châteaudun, 
Hamburg, Kremsmunster, Piacenza, Porto, 
Sevilla,Thiva 
Crop: vines 
Geometric mean valifenalate DT50lab:  0.15 d 
(normalisation to 10kPa or pF2, 20C with Q10 
of 2.58). 
KfOC: parent, arithmetic mean: 859 ml/g  
1/n= 0.96 
Geometric mean IR5839 DT50lab:  0.44 d 
(normalisation to 10kPa or pF2, 20C with Q10 
of 2.58). 
KfOC: IR5839, arithmetic mean: 63 ml/g  
1/n= 0.95 
Ff: 1 
Geometric mean PCBA DT50lab:  3.24 d 
(normalisation to 10kPa or pF2, 20C with Q10 
of 2.58). 
KfOC: PCBA, arithmetic mean: 134ml/g  
1/n= 0.97 
Ff: 0.68 Peer review of the pesticide risk assessment of the active substance valifenalate
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Application rate  Application rate: 120 g/ha. 
No. of applications:3 
Interception: 60 % 
Time of application: The date of harvest 
corresponding to each scenario described in the 
crop list by the FOCUS Group and the pre-
harvest-interval (PHI) described in the GAP 
(42 days) were used. 
 
PEC(gw) - FOCUS modelling results (80
th percentile annual average concentration at 1m) 
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Model/Crop 
PELMO 4.4.3 
vines 
Scenario Parent  (µg/L) 
valifenalate 
Metabolite (µg/L) 
IR5839 PCBA 
Chateaudun 0.000  0.000  0.000 
Hamburg 0.000  0.000  0.000 
Kremsmunster 0.000  0.000  0.000 
Piacenza 0.000  0.000  0.000 
Porto 0.000  0.000  0.000 
Sevilla 0.000  0.000  0.000 
Thiva 0.000  0.000  0.000 
 
Model/Crop 
PEARL 4.4.4 
vines 
Scenario Parent  (µg/L) 
valifenalate 
Metabolite (µg/L) 
IR5839 PCBA 
Chateaudun 0.000  0.000  0.000 
Hamburg 0.000  0.000  0.000 
Kremsmunster 0.000  0.000  0.000 
Piacenza 0.000  0.000  0.000 
Porto 0.000  0.000  0.000 
Sevilla 0.000  0.000  0.000 
Thiva 0.000  0.000  0.000 
 
Data gap for the finalisation of the ground water assessment of the aged column leachate 
metabolite S5. 
 
Fate and behaviour in air (Annex IIA, point 7.2.2, Annex III, point 9.3) 
Direct photolysis in air ‡  Not studied - no data requested 
No absorption at λ>290nm 
Photochemical oxidative degradation in air ‡  Rapidly degraded in air Atmospheric 
DT50: 7.5 hours derived by the Atkinson 
model 
(AOPWIN program utilised) 
 Volatilisation ‡  Vapour pressure: 9.6 x 10
-8 Pa at 20
oC 
  Henry's law constant:  
1.6 x 10
-6 Pa m
3mol
-1 at 20
oC and pH 5.4 
± 0.5 
 
PEC (air) 
Method of calculation 
 
No calculation, expert judgement based on 
vapour pressure, dimensionless Henry's 
Law Constant  
 
PEC(a) 
Maximum concentration 
 
Negligible 
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Environmental occurring metabolite requiring 
further assessment by other disciplines 
(toxicology and ecotoxicology) and for ground 
water exposure assessment. 
Soil: valifenalate; IR 5839; PCBA 
Ground water: valifenalate; IR 5839; 
PCBA and aged column leachate 
metabolite S5 
Surface Water: valifenalate; IR 5839; 
PCBA 
Sediment: valifenalate; IR 5839 
Air: valifenalate 
 
 
Monitoring data, if available (Annex IIA, point 7.4) 
Soil (indicate location and type of study)  No data provided - not requested 
Surface water (indicate location and type of 
study) 
 
No data provided - not requested 
Ground water (indicate location and type of 
study) 
 
No data provided - not requested 
 
Points pertinent to the classification and proposed labelling with regard to fate and 
behaviour data  
Not readily biodegradable – Candidate for R53 Peer review of the pesticide risk assessment of the active substance valifenalate
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Effects on Non-target Species 
 
Effects on terrestrial vertebrates (Annex IIA, point 8.1, Annex IIIA, points 10.1 and 
10.3) 
Species  Test substance  Time scale  End point  
 
End point 
 
Birds ‡ 
Mallard duck  IR 5885  Acute  > 2250 mg 
a.s./kg bw. 
- 
Northern bobwhite  IR 5885  Acute  > 2250 mg 
a.s./kg bw. 
- 
Japanese quail  Preparation  Acute  > 2000 mg 
form./kg bw. 
- 
  Metabolite 1  Acute  No data - not 
required 
 
Northern bobwhite  IR 5885  Short-term  > 1513 mg 
a.s./kg 
bw./day 
> 5620 
ppm a.s. 
Mallard duck  IR 5885  Short-term  > 2649 mg 
a.s./kg 
bw./day 
> 5620 
ppm a.s. 
Northern bobwhite  IR 5885  Long-term  103.7 mg 
a.s./kg 
bw./day 
1250 ppm 
a.s. 
Mallard duck  IR 5885  Long-term  167 mg 
a.s./kg 
bw./day 
1250 ppm 
a.s. 
Mammals ‡ 
Rat    IR 5885  Acute  > 5000 mg 
a.s./kg bw. 
- 
 Preparation  Acute   2000 mg/kg 
bw 
- 
Rat IR  5839 
(Metabolite) 
Acute  > 2000 mg/kg 
bw. 
- 
Rat PCBA 
(Metabolite) 
Acute 1170  mg/kg 
bw. 
- 
Rat  IR 5885  Long-term  80 mg a.s./kg 
bw./day 
1250 ppm 
a.s. 
Additional higher tier studies ‡ 
not required 
 
Toxicity/exposure ratios for terrestrial vertebrates (Annex IIIA, points 10.1 and 10.3) 
Indicator 
species/Category 
Time scale  ETE  TER  Annex VI Trigger 
Tier 1 (Birds) 
  Acute   6.48  > 347  10 
 Short-term  3.62  >  418  10 
 Long-term  3.62  29  5 
Higher tier refinement (Birds) Peer review of the pesticide risk assessment of the active substance valifenalate
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Indicator 
species/Category 
Time scale  ETE  TER  Annex VI Trigger 
 Acute      Not 
required 
10 
 Short-term    Not 
required 
10 
 Long-term    Not 
required 
5 
Tier 1 (Mammals) 
 Acute  21.27  >  235  10 
 Long-term  7.32  10.93  5 
Higher tier refinement (Mammals) 
 Acute      Not 
required 
10 
 Long-term    Not 
required 
5 
 
 
Toxicity data for aquatic species (most sensitive species of each group) (Annex IIA, point 
8.2, Annex IIIA, point 10.2)  
Group Test 
substance 
Time-scale 
(Test type) 
Endpoint Toxicity
1 
(mg/L) 
 
Laboratory tests 
Fish 
Oncorhynchus 
mykiss 
IR5885  96 hr (static)  Mortality, LC50 >  100.0  (nom) 
Brachydanio 
rerio 
IR5885  96 hr (static)  Mortality, LC50 >  100.0  (nom) 
Cyprinodon 
variegatus 
IR5885  96 hr (static)  Mortality, LC50 >  15  (mm) 
Oncorhynchus 
mykiss 
IR5885  28 d (semi-
static) 
Growth, NOEC  100.0 (nom) 
Pimephales 
promelas 
IR5885  33 d (flow-
through) 
Growth, NOEC  12.0 (nom) 
Oncorhynchus 
mykiss 
IR5885 F  96 hr (static)  Mortality, LC50 0.75  (nom) 
Oncorhynchus 
mykiss 
IR5885  F  28 d (semi-
static) 
Growth, NOEC  0.32 (nom)  
Oncorhynchus 
mykiss 
IR5839  96 hr (static)  Mortality, LC50 >  100.0  (nom) 
Oncorhynchus 
mykiss 
PCBA  96 hr (static)  Mortality, LC50 >  100.0  (nom) 
Aquatic invertebrate 
Daphnia magna  IR5885  48 hr (static)  Immobility, EC50 >  100.0  (nom) 
Americamysis 
bahia 
IR5885  96 hr (static)  Mortality, LC50 2.8  (mm) 
Daphnia magna  IR5885  22 d (semi-
static) 
Reproduction, 
NOEC 
3.2 (nom) Peer review of the pesticide risk assessment of the active substance valifenalate
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Crassostrea 
virginica 
IR5885  96 hr (static)  Shell growth, EC50 3.1  (mm) 
Daphnia magna  IR5885 F  48 hr (static)  Immobility, EC50 5.2  (nom) 
Daphnia magna  IR5885  F  21 d (semi-
static) 
Reproduction, 
NOEC 
0.032 (nom) 
Daphnia magna  IR5839  48 hr (static)  Immobility, EC50 >  100.0  (nom) 
Daphnia magna  PCBA  48 hr (static)  Immobility, EC50 >  100.0  (nom) 
Sediment dwelling organisms 
-  a.s.  28 d  NOEC  No data - not 
required 
Chironomus 
riparius 
IR5839  28 d (static)  ER, DR NOEC  100.0 (nom) 
Algae 
Scenedesmus 
subspicatus 
IR5885  72 hr (static)  Biomass: EbC50 
Growth rate: ErC50 
> 100.0 (nom)
> 100.0 (nom)
Desmodesmus 
subspicatus 
IR5885 F  72 hr (static)  Biomass: EbC50 
Growth rate: ErC50 
13.98 (nom) 
34.82 (nom) 
Desmodesmus 
subspicatus 
IR5839  72 hr (static)  Biomass: EbC50 
Growth rate: ErC50 
> 100.0 (nom) 
> 100.0 (nom) 
Desmodesmus 
subspicatus 
PCBA  72 hr (static)  Biomass: EbC50 
Growth rate: ErC50 
> 100.0 (nom) 
> 100.0 (nom) 
Higher plants 
-  a.s.  14 d  Fronds, EC50  No data - not 
required 
-  Preparation  14 d  Fronds, EC50  No data - not 
required 
-  Metabolite  14 d  Fronds, EC50  No data - not 
required 
Microcosm or mesocosm tests 
Not required. 
1 Based on nominal (nom), or mean measured (mm) concentrations. 
 
Toxicity/exposure ratios for the most sensitive aquatic organisms (Annex IIIA, point 
10.2) 
 
IR5885 and its metabolites: 
FOCUS Step 2, scenario grapes, South– EU
1 
IR5885 
 
Test 
substance 
N/S
2 Organism  Toxicity 
endpoint
 
(mg/L) 
 
Time 
scale 
PECsw,i 
(mg/L) 
TER Annex 
VI 
Trigger
IR5885  S  Fish  > 15.0  Acute  0.00332  > 4518  100 
IR5885 S  Fish  12.0  Chronic 0.00332  3614  100 
IR5885 S  Aquatic 
invertebrates 
2.8 Acute  0.00332  843  100 
IR5885 S  Aquatic 
invertebrates 
3.2 Chronic 0.00332  964  10 Peer review of the pesticide risk assessment of the active substance valifenalate
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Test 
substance 
N/S
2 Organism  Toxicity 
endpoint
 
(mg/L) 
 
Time 
scale 
PECsw,i 
(mg/L) 
TER Annex 
VI 
Trigger
IR5885  S  Algae  > 100.0  Chronic 0.00332  > 30120  10 
IR5885 S  Higher 
plants
3 
- Chronic -  - 10 
IR5885 S  Sediment-
dwelling 
organisms
3 
- Chronic -  -  10 
IR5839  S  Fish  > 100.0  Acute  0.0018  > 55555  100 
PCBA  S  Fish  > 100.0  Acute  0.00017  > 588235  100 
IR5839 S  Aquatic 
invertebrates 
> 100.0  Acute  0.0018  > 55555  100 
PCBA S  Aquatic 
invertebrates 
> 100.0  Acute  0.00017  > 588235  100 
IR5839  S  Algae  > 100.0  Chronic 0.0018  > 55555  10 
PCBA  S  Algae  > 100.0  Chronic 0.00017  > 588235  10 
IR5839 S  Sediment-
dwelling 
organisms 
100 Chronic 0.0018  55555  10 
1  This represents the worse case exposure scenario and results in the highest predicted 
environmental concentrations
 
2 Northern or Southern Europe 
3 Not required 
 
Formulation IR5885 F
1: 
 
Test 
substance 
Organism  Toxicity 
endpoint
 
(mg/L) 
 
Time 
scale 
 
TER  Annex 
VI 
Trigger 3 m  5 m  10 m  15 m  20 m 
IR5885 F 
Fish 0.75  Acute  14.04  31.12  91.46  174.42  267.86 100 
Fish 0.32  Chronic 5.99  13.28  39.02 74.42  114.29  10 
Aquatic 
Invertebrates  5.2 Acute  97.4  215.77 634.15 1209.30  1857.14  100 
Aquatic 
Invertebrates  0.032 Chronic 0.60 1.33  3.90  7.44  11.43  10 
Green Algae  13.98  Chronic 261.80 580.08 1704.88 3251.16 4992.86  10 
1 The initial maximum predicted environmental concentrations on surface water of the 
product were calculated considering the distances and the spray drift percentages indicated by 
Rautmann et al., (2001) 
 
Bioconcentration 
  IR5885 (parent)  IR5839, PCBA (metabolite) 
logPO/W  3.05-3.11 (pH7)  0.74, 2.34 (pH4) 
Bioconcentration factor (BCF) ‡  < 4
1 Not  relevant 
Annex VI Trigger for the 
bioconcentration factor 
100 Not  relevant 
Clearance time   (days)  (CT50)  Not relevant  Not relevant Peer review of the pesticide risk assessment of the active substance valifenalate
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Bioconcentration 
                                       (CT90)  Not relevant  Not relevant 
Level and nature of residues (%) in 
organisms after the 14 day depuration 
phase 
Not relevant  Not relevant 
1 Based on the average residual radioactivity in fish during exposure 
 
Effects on honeybees (Annex IIA, point 8.3.1, Annex IIIA, point 10.4) 
 
Test substance  Acute oral toxicity (LD50 
µg/bee) 
Acute contact toxicity 
(LD50 µg/bee) 
IR5885   > 106.6  > 100 
IR5885 F (Preparation)  > 200  > 184 
Metabolite 1  No data - not required No  data  - not required 
Field or semi-field tests 
No data - not required 
 
Hazard quotients for honey bees (Annex IIIA, point 10.4) 
 
Crop and application rate 
Test substance  Route  Hazard quotient  Annex VI 
Trigger 
IR5885 contact  <  1.2  50 
IR5885 oral  <  1.125  50 
Preparation   contact  < 10.8  50 
Preparation   oral  < 10  50 
 
Effects on other arthropod species (Annex IIA, point 8.3.2, Annex IIIA, point 10.5) 
 
Laboratory tests with standard sensitive species 
Species Test 
Substance 
End point  Effect 
(LR50 g/ha) 
Typhlodromus pyri ‡  IR 5885 F  Mortality  > 6400 g/ha 
Aphidius rhopalosiphi ‡  IR 5885 F  Mortality  > 9000 g/ha 
 
Crop and application rate 
Test substance  Species  Effect 
(LR50 g/ha)
HQ in-
field 
HQ off-
field 
Trigger
IR 5885 F  Typhlodromus pyri > 6400g/ha  < 0.72  Not 
required 
2 
IR 5885 F  Aphidius 
rhopalosiphi 
> 9000g/ha  < 0.51  Not 
required 
2 
 
Further laboratory and extended laboratory studies ‡ 
Species Life 
stage 
Test substance, 
substrate and 
duration 
Dose 
(g/ha) 
End point  % effect  Trigge
r 
value Peer review of the pesticide risk assessment of the active substance valifenalate
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Species Life 
stage 
Test substance, 
substrate and 
duration 
Dose 
(g/ha) 
End point  % effect  Trigge
r 
value 
No data - not 
required 
         50  % 
 
Field or semi-field tests 
No data - not required 
 
Effects on earthworms, other soil macro-organisms and soil micro-organisms (Annex 
IIA points 8.4 and 8.5. Annex IIIA, points, 10.6 and 10.7) 
 
Test organism  Test substance  Time scale  End point 
Earthworms 
Eisenia fetida  IR 5885  Acute   1,000 mg a.s./kg d.w. soil 
  IR 5885  Chronic  No data - not required 
  IR 5885 F  Acute   1,000 mg product/kg d.w. soil 
  IR 5885 F  Chronic  227.7 mg product/kg d.w. soil 
 IR  5839  Acute   1,000 mg a.s./kg d.w. soil 
  PCBA  Acute  94.8 mg a.s./kg d.w. soil 
Other soil macro-organisms 
Soil mite  a.s. ‡    No data - not required 
  Preparation    No data - not required 
  Metabolite 1    No data - not required 
Collembola 
  a.s. ‡  Chronic  No data - not required 
  Preparation    No data - not required 
  Metabolite 1    No data - not required 
Soil micro-organisms 
Nitrogen 
mineralisation 
IR 5885 F  28 days  IR5885 F had no impact on soil 
microflora nitrogen 
transformation when applied at 
concentration up to 26.67 
mg/kg soil dry weight 
(equivalent to 20 kg IR5885 F 
/ha). 
  Metabolite 1    No data - not required 
Carbon 
mineralisation 
IR 5885 F  28 days  IR5885 F had no impact on soil 
microflora carbon 
mineralisation when applied at 
concentration up to 26.67 
mg/kg soil dry weight 
(equivalent to 20 kg IR5885 F 
/ha). 
  Metabolite 1    No data - not required 
Field studies 
No data - not required 
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Toxicity/exposure ratios for soil organisms 
Crop and application rate 
Test 
organism 
Test substance  Time scale Soil PEC 
(mg/kg) 
TER Trigger
Earthworms 
  IR 5885  Acute  0.064  > 7813  10 
  IR 5885  Chronic    Not required  5 
  IR 5885 F  Acute  3.2  > 156  10 
  IR 5885 F  Chronic  3.2  35.5  5 
  IR 5839  Acute  0.0465  > 21505  10 
 PCBA  Acute  0.0143  3315  10 
Other soil macro-organisms 
Soil mite  a.s. ‡      Not required   
 Preparation      Not  required   
 Metabolites      Not  required   
Collembola  a.s. ‡      Not required   
 Preparation      Not  required   
 Metabolites      Not  required   
 
Effects on non target plants (Annex IIA, point 8.6, Annex IIIA, point 10.8) 
Based on the observations of no adverse effects on a wide range of crop types up to an 
application rate of 4 kg product/ha, it is highly unlikely that any plants beneath or within the 
crop target canopy or area will be affected at application rates of 2 kg product/ha and below.  
Plants in field margins will be exposed to drift only and therefore significantly lower amounts 
of ‘IR5885 F’ and hence any adverse effects are considered to be very unlikely. Multiple 
applications of ‘IR5885 F’ are not considered to pose a higher risk to plants given that 
valifenalate and folpet dissipate on and are metabolised in plants. 
 
Effects on biological methods for sewage treatment (Annex IIA 8.7)  
Test type/organism  end point 
Micro-organisms of activated sludge  EC50 is higher than 100 mg IR5885/activated 
sludge L (i.e. higher than the limit of solubility 
that is 2.4 x 10
-2 mg/L). At pH 7 and pH 9 
Valifenalate (IR5885) hydrolyses very quickly 
and so if any contamination of sewage 
treatment works did occur the compound would 
be hydrolysed very rapidly. 
 
Ecotoxicologically relevant compounds (consider parent and all relevant metabolites 
requiring further assessment from the fate section) 
Compartment  
soil  IR5885 (parent), IR5839 (metabolite), PCBA (metabolite) 
water  IR5885 (parent), IR5839 (metabolite), PCBA (metabolite) 
sediment IR5839  (metabolite), 
groundwater None. 
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Classification and proposed labelling with regard to ecotoxicological data (Annex IIA, 
point 10 and Annex IIIA, point 12.3) 
  RMS/peer review proposal  
Active substance: IR 5885   Hazard symbol: ‘N’. 
Indication of danger: ‘Dangerous for the 
environment’. 
Risk phrases: R51, 53. 
Safety phrases: S61. 
  RMS/peer review proposal  
Preparation: IR 5885 F (Java F)  Hazard symbol: ‘N’. 
Indication of danger: ‘Dangerous for the 
environment’. 
Risk phrases: R50, 53. 
Safety phrases: S35, S57.   Peer review of the pesticide risk assessment of the active substance valifenalate
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APPENDIX B – USED COMPOUND CODE(S) 
Code/Trivial name*  Chemical name  Structural formula 
IR-5839 
(IR5885-acid, S2) 
(3RS)-3-(4-chlorophenyl)-3-{[N-
(isopropoxycarbonyl)-L-
valyl]amino}propanoic acid 
or 
N-(isopropoxycarbonyl)-L-valyl-(3RS)-3-
(4-chlorophenyl)-β-alanine 
C H3
CH3
O
O
NH
C H3 CH3
O
NH
O
OH
Cl
 
PCBA 
(S3) 
4-chlorobenzoic acid 
 
O HO
Cl
 
S5  Pending characterization   Pending characterization  
ß-pCl-phenylalanine  (3RS)-3-amino-3-(4-
chlorophenyl)propanoic acid 
or 
3-(4-chlorophenyl)-DL-β-alanine  N H2
O
OH
Cl
 
Folpet  N-(trichloromethylthio)phthalimide 
or 
N-(trichloromethanesulfenyl)phthalimide 
N
O
O
S
Cl
Cl
Cl  
* The metabolite name in bold is the name used in the conclusion. 
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ABBREVIATIONS 
1/n  slope of Freundlich isotherm 
λ wavelength 
  decadic molar extinction coefficient 
°C  degree Celsius (centigrade) 
µg microgram 
µm micrometer  (micron) 
a.s. active  substance 
AChE acetylcholinesterase 
ADE  actual dermal exposure 
ADI  acceptable daily intake 
AF assessment  factor 
AOEL  acceptable operator exposure level 
AP alkaline  phosphatase 
AR applied  radioactivity 
ARfD  acute reference dose 
AST  aspartate aminotransferase (SGOT) 
AV avoidance  factor 
BCF bioconcentration  factor 
BUN  blood urea nitrogen 
bw body  weight 
CAS  Chemical Abstracts Service 
CFU  colony forming units 
ChE cholinesterase 
CI confidence  interval 
CIPAC  Collaborative International Pesticides Analytical Council Limited 
CL confidence  limits 
cm centimetre 
d day 
DAA  days after application 
DAD  diode array detector 
DAR  draft assessment report 
DAT  days after treatment 
DM dry  matter 
DT50  period required for 50 percent disappearance (define method of estimation) 
DT90  period required for 90 percent disappearance (define method of estimation) 
dw dry  weight 
EbC50  effective concentration (biomass) 
EC50 effective  concentration 
ECHA  European Chemical Agency 
EEC  European Economic Community 
EINECS  European Inventory of Existing Commercial Chemical Substances 
ELINCS  European List of New Chemical Substances 
EMDI  estimated maximum daily intake 
ER50  emergence rate/effective rate, median 
ErC50  effective concentration (growth rate) 
EU European  Union 
EUROPOEM  European Predictive Operator Exposure Model 
f(twa)  time weighted average factor 
FAO  Food and Agriculture Organisation of the United Nations 
FIR  Food intake rate 
FOB  functional observation battery 
FOCUS  Forum for the Co-ordination of Pesticide Fate Models and their Use Peer review of the pesticide risk assessment of the active substance valifenalate
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g gram 
GAP  good agricultural practice 
GC gas  chromatography 
GCPF  Global Crop Protection Federation (formerly known as GIFAP) 
GGT  gamma glutamyl transferase 
GM geometric  mean 
GS growth  stage 
GSH glutathion 
h hour(s) 
ha hectare 
hL hectolitre 
HPLC  high pressure liquid chromatography  
or high performance liquid chromatography 
HPLC-MS  high pressure liquid chromatography – mass spectrometry 
HPLC-MS/MS  high performance liquid chromatography with tandem mass spectrometry 
HPLC-UV  high performance liquid chromatography with ultra violet detector 
HRGC/ECD  high resolution gas chromatography with electron capture detector  
HQ hazard  quotient 
IEDI  international estimated daily intake 
IESTI  international estimated short-term intake 
ISO  International Organisation for Standardisation 
IUPAC International  Union  of  Pure and Applied Chemistry 
JMPR  Joint Meeting on the FAO Panel of Experts on Pesticide Residues in Food and 
the Environment and the WHO Expert Group on Pesticide Residues (Joint 
Meeting on Pesticide Residues) 
Kdoc  organic carbon linear adsorption coefficient 
kg kilogram 
KFoc  Freundlich organic carbon adsorption coefficient 
L litre 
LC liquid  chromatography 
LC50  lethal concentration, median 
LC-MS  liquid chromatography-mass spectrometry 
LC-MS-MS  liquid chromatography with tandem mass spectrometry 
LD50  lethal dose, median; dosis letalis media 
LDH lactate  dehydrogenase 
LOAEL  lowest observable adverse effect level 
LOD  limit of detection 
LOQ  limit of quantification (determination) 
m metre 
M/L  mixing and loading 
MAF  multiple application factor 
MCH  mean corpuscular haemoglobin 
MCHC  mean corpuscular haemoglobin concentration 
MCV  mean corpuscular volume 
mg milligram 
mL millilitre 
mm millimetre 
mN milli-newton 
MRL  maximum residue limit or level 
MS mass  spectrometry 
MTD  maximum tolerated dose 
MWHC  maximum water holding capacity 
NESTI national  estimated short-term intake 
ng nanogram 
NOAEC  no observed adverse effect concentration Peer review of the pesticide risk assessment of the active substance valifenalate
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NOAEL  no observed adverse effect level 
NOEC  no observed effect concentration 
NOEL  no observed effect level 
OECD  Organisation for Economic Co-operation and Development  
OM  organic matter content 
Pa pascal 
PD  proportion of different food types 
PEC  predicted environmental concentration 
PECair  predicted environmental concentration in air 
PECgw  predicted environmental concentration in ground water 
PECsed  predicted environmental concentration in sediment 
PECsoil  predicted environmental concentration in soil 
PECsw  predicted environmental concentration in surface water 
pH pH-value 
PHED  pesticide handler's exposure data 
PHI pre-harvest  interval 
PIE  potential inhalation exposure 
pKa  negative logarithm (to the base 10) of the dissociation constant 
Pow  partition coefficient between n-octanol and water 
PPE  personal protective equipment 
ppm  parts per million (10
-6) 
ppp  plant protection product 
PT  proportion of diet obtained in the treated area 
QSAR  quantitative structure-activity relationship 
r
2  coefficient of determination 
REACH  Registration, Evaluation, Authorisation of CHemicals  
RPE  respiratory protective equipment 
RUD  residue per unit dose 
SC suspension  concentrate 
SD standard  deviation 
SFO single  first-order 
SSD species  sensitivity  distribution 
STMR  supervised trials median residue 
t1/2  half-life (define method of estimation) 
TER  toxicity exposure ratio 
TERA  toxicity exposure ratio for acute exposure 
TERLT  toxicity exposure ratio following chronic exposure 
TERST  toxicity exposure ratio following repeated exposure 
TMDI  theoretical maximum daily intake 
TRR  total radioactive residue 
TSH  thyroid stimulating hormone (thyrotropin) 
TWA  time weighted average 
UDS unscheduled  DNA  synthesis 
USDA  United States Department of Agriculture 
UV ultraviolet 
W/S water/sediment 
w/v  weight per volume 
w/w  weight per weight 
WBC  white blood cell 
WG  water dispersible granule 
WHO  World Health Organisation 
wk week 
yr year 
 